These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

299 related articles for article (PubMed ID: 25955568)

  • 1. Characterization of glioma stem-like cells from human glioblastomas.
    Yamamuro S; Okamoto Y; Sano E; Ochiai Y; Ogino A; Ohta T; Hara H; Ueda T; Nakayama T; Yoshino A; Katayama Y
    Int J Oncol; 2015 Jul; 47(1):91-6. PubMed ID: 25955568
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cell surface Nestin is a biomarker for glioma stem cells.
    Jin X; Jin X; Jung JE; Beck S; Kim H
    Biochem Biophys Res Commun; 2013 Apr; 433(4):496-501. PubMed ID: 23524267
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The ultrastructural difference between CD133-positive U251 glioma stem cells and normal U251 glioma cells.
    Yang B; Wang Y; Yang C; Ouyang W; Zhou F; Zhou Y; Xie C
    Ultrastruct Pathol; 2012 Dec; 36(6):404-8. PubMed ID: 23216238
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antitumorigenic effect of interferon-β by inhibition of undifferentiated glioblastoma cells.
    Yamamuro S; Sano E; Okamoto Y; Ochiai Y; Ohta T; Ogino A; Natsume A; Wakabayashi T; Ueda T; Hara H; Nakayama T; Yoshino A; Katayama Y
    Int J Oncol; 2015 Nov; 47(5):1647-54. PubMed ID: 26397698
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CD133+ glioblastoma stem-like cells induce vascular mimicry in vivo.
    Chiao MT; Yang YC; Cheng WY; Shen CC; Ko JL
    Curr Neurovasc Res; 2011 Aug; 8(3):210-9. PubMed ID: 21675958
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Type 1 collagen as a potential niche component for CD133-positive glioblastoma cells.
    Motegi H; Kamoshima Y; Terasaka S; Kobayashi H; Houkin K
    Neuropathology; 2014 Aug; 34(4):378-85. PubMed ID: 24673436
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enhanced invasion in vitro and the distribution patterns in vivo of CD133+ glioma stem cells.
    Yu SP; Yang XJ; Zhang B; Ming HL; Chen C; Ren BC; Liu ZF; Liu B
    Chin Med J (Engl); 2011 Sep; 124(17):2599-604. PubMed ID: 22040410
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ADAM17 regulates self-renewal and differentiation of U87 glioblastoma stem cells.
    Chen X; Chen L; Zhang R; Yi Y; Ma Y; Yan K; Jiang X; Wang X
    Neurosci Lett; 2013 Mar; 537():44-9. PubMed ID: 23356982
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A new 2-pyrone derivative, 5-bromo-3-(3-hydroxyprop-1-ynyl)-2H-pyran-2-one, suppresses stemness in glioma stem-like cells.
    Kim RK; Kim MJ; Yoon CH; Lim EJ; Yoo KC; Lee GH; Kim YH; Kim H; Jin YB; Lee YJ; Cho CG; Oh YS; Gye MC; Suh Y; Lee SJ
    Mol Pharmacol; 2012 Sep; 82(3):400-7. PubMed ID: 22648970
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plastic induction of CD133AC133-positive cells in the microenvironment of glioblastoma spheroids.
    Ohnishi K; Tani T; Bando S; Kubota N; Fujii Y; Hatano O; Harada H
    Int J Oncol; 2014 Aug; 45(2):581-6. PubMed ID: 24897999
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Astrocytes enhance the invasion potential of glioblastoma stem-like cells.
    Rath BH; Fair JM; Jamal M; Camphausen K; Tofilon PJ
    PLoS One; 2013; 8(1):e54752. PubMed ID: 23349962
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Adherent culture of CD133+ cells in glioblastomas and expression of ADLH1].
    Wang P; Mao Q; Wang X; Chen MN; Gan LA; Liu YH
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2011 May; 42(3):413-6. PubMed ID: 21827011
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stem cell characteristics in glioblastoma are maintained by the ecto-nucleotidase E-NPP1.
    Bageritz J; Puccio L; Piro RM; Hovestadt V; Phillips E; Pankert T; Lohr J; Herold-Mende C; Lichter P; Goidts V
    Cell Death Differ; 2014 Jun; 21(6):929-40. PubMed ID: 24531536
    [TBL] [Abstract][Full Text] [Related]  

  • 14. β-elemene inhibits stemness, promotes differentiation and impairs chemoresistance to temozolomide in glioblastoma stem-like cells.
    Zhu TZ; Li XM; Luo LH; Song ZQ; Gao X; Li ZQ; Su JY; Liang GB
    Int J Oncol; 2014 Aug; 45(2):699-709. PubMed ID: 24841897
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neural stem cells and glioblastoma.
    Rispoli R; Conti C; Celli P; Caroli E; Carletti S
    Neuroradiol J; 2014 Apr; 27(2):169-74. PubMed ID: 24750704
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modulation of invasive properties of CD133+ glioblastoma stem cells: a role for MT1-MMP in bioactive lysophospholipid signaling.
    Annabi B; Lachambre MP; Plouffe K; Sartelet H; Béliveau R
    Mol Carcinog; 2009 Oct; 48(10):910-9. PubMed ID: 19326372
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeting brain-tumor stem cells.
    Stupp R; Hegi ME
    Nat Biotechnol; 2007 Feb; 25(2):193-4. PubMed ID: 17287755
    [No Abstract]   [Full Text] [Related]  

  • 18. The presence of stem cell marker-expressing cells is not prognostically significant in glioblastomas.
    Kim KJ; Lee KH; Kim HS; Moon KS; Jung TY; Jung S; Lee MC
    Neuropathology; 2011 Oct; 31(5):494-502. PubMed ID: 21269333
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CD133/CD15 defines distinct cell subpopulations with differential in vitro clonogenic activity and stem cell-related gene expression profile in in vitro propagated glioblastoma multiforme-derived cell line with a PNET-like component.
    Kahlert UD; Bender NO; Maciaczyk D; Bogiel T; Bar EE; Eberhart CG; Nikkhah G; Maciaczyk J
    Folia Neuropathol; 2012; 50(4):357-68. PubMed ID: 23319191
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CD133 is essential for glioblastoma stem cell maintenance.
    Brescia P; Ortensi B; Fornasari L; Levi D; Broggi G; Pelicci G
    Stem Cells; 2013 May; 31(5):857-69. PubMed ID: 23307586
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.